CRVO

CervoMed Inc.

13.78 USD
-0.16 (-1.15%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

CervoMed Inc. stock is up 52.94% since 30 days ago. The next earnings date is Mar 22, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 44% of the previous 27 February’s closed higher than January. 100% of analysts rate it a buy.

About CervoMed Inc.

CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of drug treatments for neurodegenerative diseases. It develops neflamapimod, an orally administered small molecule brain penetrant for the treatment of dementia with Lewy bodies (DLB), Alzheimer's diseases, and brain stroke recovery. The company is based in Boston, Massachusetts.